Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma. - Wikidata - wikimedia - TriplyDB

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma.

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma.

http://www.wikidata.org/entity/Q35095028

about

The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies Prognostic factors in hodgkin lymphoma FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma.Primary mediastinal large B-cell lymphoma.Primary mediastinal lymphoma: diagnosis and treatment options.Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines.Cell Transformation by PTP1B Truncated Mutants Found in Human Colon and Thyroid Tumors.Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma.Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.The genetics of nodal marginal zone lymphoma Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era.Genetic alterations of protein tyrosine phosphatases in human cancers.Structural genomic alterations in primary mediastinal large B-cell lymphoma.Cancer genomics: why rare is valuable.Recurrent genomic rearrangements in primary testicular lymphoma.Molecular deregulation of signaling in lymphoid tumors.The role of next-generation sequencing in understanding the genomic basis of diffuse large B cell lymphoma and advancing targeted therapies.Genetic landscape and deregulated pathways in B-cell lymphoid malignancies.An update on genomic-guided therapies for pediatric solid tumors.Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.Childhood, adolescent and young adult non-Hodgkin lymphoma: state of the science.Activating STAT6 mutations in follicular lymphoma.Diagnosis and classification of hematologic malignancies on the basis of genetics.Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome.Clonal B cells in Waldenström's macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling.Targeting STAT6 in PMBL.KIT mutations in primary mediastinal B-cell lymphoma.Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma.JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders.Aggressive B-cell lymphomas in the update of the 4th edition of the World Health Organization classification of haematopoietic and lymphatic tissues: refinements of the classification, new entities and genetic findings.Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets.Recurrent genetic defects in classical Hodgkin lymphoma cell lines.Ruxolitinib significantly enhances in vitro apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine model.The Microenvironment in Epstein-Barr Virus-Associated Malignancies.

P2860

Q26745842-76DB6DF6-8782-4413-AC58-EC719696CB68 Q33622342-B50B7F11-7BCF-420A-BB2A-BE1FD271DAFA Q33886267-FB0602FD-1733-46D4-ADA2-0779B8104A42 Q33920147-4585F8C7-98CE-40DC-AFDC-947A64A56ED8 Q34221760-782FA0C7-D8C7-4BE0-A641-ACE382666C6C Q34266819-0F75FFE5-059C-4A8D-98D3-8A48270219C9 Q34455499-D83015C3-1AC3-4D85-80E0-585586CCFB80 Q34802443-6A309803-6FF5-47B1-9E1A-45F2B73391B4 Q35671227-536ED6FF-5966-4A27-9926-909280B4D8E9 Q35850206-F934982F-CF80-4929-8143-150A182175D0 Q36195241-8A0976C2-986F-4E5A-9EF6-D2B3C55BC4A9 Q36463861-5E134F6C-AC3C-4C04-A612-F87C8D6F678F Q37237891-9F8022E4-1514-4809-A704-D83B92BDD86E Q37243257-359AD6C5-BD3C-4F7A-BEA5-7BFB3AD00CFB Q37725413-D7F3756F-F5A7-4700-92C1-250005653540 Q38240579-D87F6248-BEE5-40DD-85EA-F3EC4F47B8E6 Q38255066-2D61C895-80F5-4BB3-89DB-0DFB5875EA07 Q38267888-D1C17097-DBE7-401D-BDBA-0246C1E59547 Q38353573-6D082BD0-5016-40B1-BF98-7EA09925E1CF Q38387704-D222F979-D09A-41B2-AE14-7E11D789803F Q38424403-2D6A5A4F-7FF4-4ADA-9695-D1D810965C1D Q38664822-76031902-0F8E-418A-9636-92B506FA0329 Q38669131-0308A19F-4E23-4B39-BDB6-4742EF962FBB Q38673827-AD2E46E9-FD8B-4E3B-8ACC-7B46528427C6 Q38764010-EBE42245-33FF-4982-BE05-2F1E76FCFD55 Q38822525-2D9BC454-2268-4D03-AF5A-FFE41734CAFD Q38937478-58B4BC7F-03F4-43DA-B980-E83845A8DB64 Q39363409-3ADC72A5-DB86-490B-AE65-23FB9EC0CC7C Q39406673-D3B65853-76F2-4218-85EB-390DA3C6F6BE Q40649778-F6EE0C57-D189-4606-BB7D-86DD40A15A3C Q41081977-6C92F9B6-40DB-44C0-BAC0-50AB5C96102D Q42950480-21D9C220-7841-4C89-801B-DFFB3B9411C9 Q42974506-64E254D0-CF3B-4C02-9979-72C5F18896E4 Q47372804-4BC3AC0F-A75E-42C9-B388-8ED5DD7371DB Q48109284-DECF27FF-D7CD-4106-8F48-045DF0CABA55 Q48338600-B069C084-E49E-436A-8729-D190DF340E4A Q49592738-4E426B6F-1522-41C9-8412-83F89757F672 Q50657891-B5D19A02-1EDB-4345-8CFE-A741E276CBE6 Q52668197-88586F75-ADA7-40B8-85BD-F88722758441 Q54236409-0CB3EA05-2F95-4CCB-BA6B-83241490DDC1

P2860

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma.

http://www.wikidata.org/entity/Q35095028

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Recurrent somatic mutations of ...... lymphoma and Hodgkin lymphoma.

@ast

Recurrent somatic mutations of ...... lymphoma and Hodgkin lymphoma.

@en

type

label

Recurrent somatic mutations of ...... lymphoma and Hodgkin lymphoma.

@ast

Recurrent somatic mutations of ...... lymphoma and Hodgkin lymphoma.

@en

prefLabel

Recurrent somatic mutations of ...... lymphoma and Hodgkin lymphoma.

@ast

Recurrent somatic mutations of ...... lymphoma and Hodgkin lymphoma.

@en

P1433

Q35095028-7889B105-BE07-4E14-8B34-34C06CD6D325

P1476

Q35095028-4FEB7472-DECA-4E03-B46B-C27B4C274C7B

P2093

Q35095028-009DF057-473D-461B-8B7F-976BCE6991E6

Q35095028-05336350-BAD9-4770-BBA2-16075AE515A9

Q35095028-23B15535-9BEA-4314-BB57-7398C16D6FB1

Q35095028-2AD33851-202C-4938-AFE2-0E0F670FB38E

Q35095028-3524D3DB-BF5E-4151-B8D5-9391E06D29BB

Q35095028-36286124-848F-466F-A3FF-6955B769F96D

Q35095028-3791DC21-27E8-4FB0-BC33-4BD7F1431921

Q35095028-39A8BE97-74E1-47D9-B575-421373ADF116

Q35095028-5E4C3756-248F-44C1-A438-E97C913E9BC1

Q35095028-5E7E43C8-A308-4824-849A-847BF6B5340E

P2888

Q35095028-284B3DEA-9E7D-41CB-9D2B-457D2F2C4CC1

P304

Q35095028-FF561722-8064-4ECC-88C5-900C9154ECC9

P31

Q35095028-144E6139-85A9-496D-A0E0-84E4897FA2C4

P356

Q35095028-A138E075-6077-4B24-B105-7331B1931123

P407

Q35095028-4BDC929E-5125-43C1-A605-4E897D8F6FED

P433

Q35095028-25A4C74C-6757-4B7E-8F4A-44704CB7CCC8

P478

Q35095028-A62136D4-5380-497A-8265-D4A479975626

P50

Q35095028-13CC1DF0-5501-464C-B1E1-74BA30316B42

Q35095028-74D227EE-654E-4AC4-9E3E-9865878D9292

Q35095028-7B99AC29-C685-40B2-BAB2-54FBB3F06A85

Q35095028-EF290EE4-A915-4075-873B-B1419D943D5C

Q35095028-F4CD5F10-8FC5-4EB5-81C5-2F2ED089744E

P577

Q35095028-683C9591-9EE7-4DA6-8E0F-89BB63A8941E

P698

Q35095028-D576AD98-4859-4BAC-90CD-3C23A0C1F09A

P356

P1433

Nature Genetics

P1476

Recurrent somatic mutations of ...... lymphoma and Hodgkin lymphoma.

@en

P2093

Adèle Telenius

http://www.w3.org/2001/XMLSchema#string

Anja Mottok

http://www.w3.org/2001/XMLSchema#string

Bruce Woolcock

http://www.w3.org/2001/XMLSchema#string

Christian Steidl

http://www.w3.org/2001/XMLSchema#string

Chrystelle Guiter

http://www.w3.org/2001/XMLSchema#string

Fong Chun Chan

http://www.w3.org/2001/XMLSchema#string

Kerry J Savage

http://www.w3.org/2001/XMLSchema#string

King L Tan

http://www.w3.org/2001/XMLSchema#string

Lisa M Rimsza

http://www.w3.org/2001/XMLSchema#string

Marco A Marra

http://www.w3.org/2001/XMLSchema#string

P2888

P304

329-335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NG.2900

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

Joseph M Connors

Jay Gunawardana

Randy D Gascoyne

P577

2014-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24531327

http://www.w3.org/2001/XMLSchema#string